Lu-xi Song

发表

Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

Saijuan Chen, Lanping Xu, Xiao Li, 2016, Tumor Biology.

Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes: Cytogenetic Characterization

Xiao Li, Chun-kang Chang, Qi He, 2012, Acta Haematologica.

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2021, Clinical Epigenetics.

Cerebral venous and sinus thrombosis in a patient with acute promyelocytic leukemia during all-trans retinoic acid induction treatment.

Xiao Li, Chun-kang Chang, Lu-xi Song, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome

Sida Zhao, Zheng Zhang, Chun-kang Chang, 2022, Cancers.

Efficacy and toxicity of decitabine versus CHG regimen (low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor) in patients with higher risk myelodysplastic syndrome: a retrospective study

Xiao Li, Chun-kang Chang, Lingyun Wu, 2016, Leukemia & lymphoma.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Cheng-Long Hu, Juan Guo, Lingyun Wu, 2023, Science Advances.

NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy

Xiao Li, Chun-kang Chang, Juan Guo, 2020, British Journal of Haematology.

The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine

Xiao Li, Chun-kang Chang, Y. Tao, 2019, Journal of Cancer Research and Clinical Oncology.

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes

Xiao Li, Chun-kang Chang, Feng Xu, 2017, Scientific Reports.

TP53 mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2017, British journal of haematology.

The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS

Chun-kang Chang, Lu-xi Song, C. Xiao, 2022, Frontiers in Oncology.

Primary lymphoma of bone: a case report and review of the literature

Xiao Li, Chun-kang Chang, Lingyun Wu, 2011, Medical oncology.

Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation

Yan Jia, Chun-kang Chang, Juan Guo, 2020, Frontiers in Genetics.

Analysis of the influencing factors related to liver and cardiac iron overload in MDS patients detected by MRI in the real world

Yan Jia, Xiao Li, Chun-kang Chang, 2021, Hematology.

Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.

Sida Zhao, Xiao Li, Chun-kang Chang, 2017, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia

Xiao Li, Chun-kang Chang, Lingyun Wu, 2012, Annals of Hematology.

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome

Chun-kang Chang, Juan Guo, Lingyun Wu, 2021, Frontiers in Oncology.